Heart‐derived factors and organ cross‐talk in settings of health and disease: new knowledge and clinical opportunities for multimorbidity
- 31 January 2025
- journal article
- research article
- Published by Wiley in The Journal of Physiology
- Vol. 604 (16) , 6572-6600
Abstract
Cardiovascular disease affects millions of people worldwide and often presents with other conditions including metabolic, renal and neurological disorders. A variety of secreted factors from multiple organs/tissues (proteins, nucleic acids and lipids) have been implicated in facilitating organ cross‐talk that may contribute to the development of multimorbidity. Secreted proteins have received the most attention, with the greatest body of research related to factors released from adipose tissue (adipokines), followed by skeletal muscle (myokines). To date, there have been fewer studies on proteins released from the heart (cardiokines) implicated with organ cross‐talk. Early evidence for the secretion of cardiac‐specific factors facilitating organ cross‐talk came in the form of natriuretic peptides which are secreted via the classical endoplasmic reticulum–Golgi pathway. More recently, studies in cardiomyocyte‐specific genetic mouse models have revealed cardiac‐initiated organ cross‐talk. Cardiomyocyte‐specific modulation of microRNAs (miR‐208a and miR‐23‐27‐24 cluster) and proteins such as the mediator complex subunit 13 (MED13), G‐protein‐coupled receptor kinase 2 (GRK2), mutant α‐myosin heavy‐chain (αMHC), ubiquitin‐like modifier‐activating enzyme (ATG7), oestrogen receptor alpha (ERα) and fibroblast growth factor 21 (FGF21) have resulted in metabolic and renal phenotypes. These studies have implicated a variety of factors which can be secreted via the classical pathway or via non‐classical mechanisms including the release of extracellular vesicles. Cross‐talk between the heart and the brain has also been described (e.g. via miR‐1 and an emerging concept, interoception: detection of internal neural signals). Here we summarize these studies taking into consideration that factors may be secreted in both settings of health and in disease. imageKeywords
This publication has 162 references indexed in Scilit:
- AHNAK2 Participates in the Stress‐Induced Nonclassical FGF1 Secretion PathwayJournal of Cellular Biochemistry, 2015
- Metabolic crosstalk between the heart and liver impacts familial hypertrophic cardiomyopathyEMBO Molecular Medicine, 2014
- FGF‐21/FGF‐21 receptor interaction and activation is determined by βKlothoJournal of Cellular Physiology, 2007
- Myocardial ischemia enhances the expression of acidic fibroblast growth factor in human pericardial fluid.Heart and Vessels, 2000
- Expression of natriuretic peptide receptors in human adipose and other tissuesJournal of Endocrinological Investigation, 1996
- Quantitative export of FGF‐2 occurs through an alternative, energy‐dependent, non‐ER/Golgi pathwayJournal of Cellular Physiology, 1995
- Atrial natriuretic peptide‐like (ANP‐LIR) and ANP prohormone immunoreactive astrocytes and neurons of human cerebral cortexGlia, 1994
- Secretion of the Baby Hamster Kidney 30-kDa Galactose-Binding Lectin from Polarized and Nonpolarized Cells: A Pathway Independent of the Endoplasmic Reticulum-Golgi ComplexExperimental Cell Research, 1993
- Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum‐Golgi complexJournal of Cellular Physiology, 1992
- A novel secretory pathway for interleukin‐1 beta, a protein lacking a signal sequence.The EMBO Journal, 1990